‘No More Paying For The Rich World’s Medicine’ – White House 13/02/2019 by Intellectual Property Watch 1 Comment Share this Story:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window) IP-Watch is a non-profit independent news service and depends on subscriptions. To access all of our content, please subscribe here. You may also offer additional support with your subscription, or donate. The Trump administration yesterday made some firm statements about reducing health care and drug prices for American consumers and making costs more transparent. The statements again appear to focus on other countries paying more for US-made drugs but also promote generic drugs. Below is an item from 12 February on the 1600 Daily blog: No more paying for the rich world’s medicine After today’s Cabinet meeting, Health and Human Services Secretary Alex Azar took a moment to explain how America’s seniors are footing the drug bills for patients in some of the richest countries in the world. “So under President Trump, what we’ve found is that in our Medicare program for senior citizens, for the drugs that doctors administer in their offices to patients . . . we’re paying 180 percent of what the Europeans, the Canadians, and the Japanese are paying for the exact same drugs,” Secretary Azar says. “Pharma is making all their profit here in the United States, and then they’re giving these sweetheart deals in the other countries.” Putting American patients first has been core to President Trump’s agenda since day one. Last week, during his second State of the Union address, he called on Congress to join him: “The next major priority for me, and for all of us, should be to lower the cost of healthcare and prescription drugs, and to protect patients with preexisting conditions.” Already, President Trump’s efforts to put patients in control have resulted in the single largest decline in drug prices in 46 years. The FDA approved a record number of generic drugs in 2017 and 2018 as alternatives to expensive brand-name medicines. All told, these approvals have saved customers a staggering $26 billion. The next chapter in the fight against high drug prices is increasing transparency and ending the practice of global free-riding. Hospitals, insurance companies, and drug companies should be required to disclose real prices to patients to drive costs down. And Americans must get a share of whatever discounts other wealthy countries receive. “This is wrong, this is unfair, and together we will stop it,” President Trump said last Tuesday. “And we’ll stop it fast.” Watch: It’s time to stop paying for the rich world’s medicine. Read: “How Team Trump is bringing drug prices down” For years, the pharma industry has profited by charging American patients more while giving sweetheart deals to other countries across the globe. No more. The days of America paying for the rich world's medicine are over. 1600 Daily: https://t.co/A68ueVC88u pic.twitter.com/TLPX6Mldc1 — The White House (@WhiteHouse) February 13, 2019 Image Credits: White House Share this Story:Click to share on Twitter (Opens in new window)Click to share on LinkedIn (Opens in new window)Click to share on Facebook (Opens in new window)Click to email this to a friend (Opens in new window)Click to print (Opens in new window) Related "‘No More Paying For The Rich World’s Medicine’ – White House" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.